Taiwei Biotech International

Biotech firm

🤖

AI Overview

With $300K in lobbying spend across 7 quarterly filings, Taiwei Biotech International is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2022.

$300K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$300K
2022$0

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Taiwei Biotech International disclosed contacting in their lobbying filings.

SENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade, Health Issues

Assist client with exporting pharmaceutical products.

Assisting with obtaining COVID vaccines for private entities

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.